Chambers UK 2025 has highly ranked a record number of Goodwin lawyers and practices across the firm’s UK platform. Chambers' rankings are based on independent research collected from thousands of interviews with clients and law firms. This year, Goodwin lawyers received 35 rankings and 15 practice areas were recognized for excellence.
The firm added new rankings this year in Complex Litigation & Dispute Resolution, M&A, Healthcare, Secondaries, Real Estate Investment Funds, Private Investment Funds, and Data, Privacy & Cybersecurity. It also built upon on its success in Banking & Finance, Intellectual Property, Venture Capital, Financial Restructuring, Hospitality and Leisure, Life Sciences, Private Equity, Real Estate, and Tax.
Client feedback praised Goodwin’s ability to “consistently demonstrate exceptional expertise and proficiency in handling complex matters,” and noted that the “depth of their team reflects a robust range of expertise.”
Chambers UK 2025 ranked Goodwin as a leading law firm in:
East Anglia
- Intellectual Property
London
- Banking & Finance: Sponsors
- Commercial and Corporate Litigation
- Corporate/M&A: £100-800 million
- Real Estate: £50-150 million
- Restructuring/Insolvency
- Tax
UK-Wide
- Healthcare: Private Sector
- Hotels & Leisure
- Investment Funds: Private Equity
- Investment Funds: Private Equity: Secondaries
- Investment Funds: Real Estate
- Life Sciences: Transactional
- Private Equity: Buyouts: Up to £500 million
- Private Equity: Venture Capital Investment
Goodwin lawyers ranked by Chambers UK include:
- Malcolm Bates - Life Sciences: Transactional (UK-Wide) / Intellectual Property (East Anglia)
- Mark Beardsworth – Corporate Crime & Investigations (London) / Financial Crimes: Corporates (London)
- Matthew Birchall - Tax (London)
- Laura Charkin - Tax: Investment Funds (London)
- Justin Cornelius - Investment Funds: Real Estate (UK-Wide)
- Patrick Deasy - Investment Funds: Private Equity (UK-Wide)
- Graham Defries - Life Sciences: Transactional (UK-Wide)
- David Evans - Investment Funds: Real Estate (UK-Wide)
- Simon Fulbrook - Banking & Finance: Mid-Market (London)
- James Grimwood - Private Equity: Buyouts: Up to £500 million (UK-Wide)
- Michael Halford - Investment Funds: Private Equity (UK-Wide)
- Ed Hall - Investment Funds: Private Equity (UK-Wide)
- David Irvine - Tax (London)
- Oliver Glynn-Jones - Corporate and Commercial Litigation (London)
- Richard Lever - Private Equity: Buyouts: Up to £500 million (UK-Wide)
- Paul Lyons - Real Estate Finance (London)
- David Mardle - Life Sciences: Transactional (UK-Wide) / Private Equity: Venture Capital Investment (UK-Wide)
- Curtis McCluskey - Data Protection & Information Law (UK-Wide)
- Sophie McGrath – Healthcare: Corporate/Commercial (UK-Wide) / Venture Capital Investment (UK-Wide)
- Sarah McAtominey - Corporate and Commercial Litigation (London)
- Bhargavi Mudakavi - Investment Funds: Real Estate (UK-Wide)
- Geoff O’Dea - Restructuring/Insolvency (London)
- Ajay Pathak - Investment Funds: Private Equity (UK-Wide)
- Matthew Pohlman - Hotels & Leisure (UK-Wide)
- Georgia Powell - Intellectual Property (East Anglia)
- Elizabeth Rhodes - Venture Capital Investment (UK-Wide)
- Martin Smith - Real Estate: £50-150 million (London)
- Simon Thomas - Restructuring/Insolvency (London)
- Thiha Tun - Investment Funds: Private Equity: Secondaries (UK-Wide)
- Tim Worden - Life Sciences: Transactional (UK-Wide) / Intellectual Property (East Anglia)
To learn more about Goodwin’s results, visit Chambers UK 2025.